Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

SOPs for Analytical Method Development V 2.0

Analytical Method Development: Morphology Assessment SOP – V 2.0

Posted on By

The purpose of this SOP is to define the procedures for assessing the morphology of active pharmaceutical ingredients (APIs), excipients, and formulated products using validated microscopic techniques, including optical microscopy and Scanning Electron Microscopy (SEM), in the Analytical Method Development (AMD) laboratory.
Click to read the full article.

Analytical Method Development V 2.0

Analytical Method Development: Microbial Limit Test Method Development – V 2.0

Posted on By

This SOP outlines the procedure for developing and optimizing Microbial Limit Test (MLT) methods to detect and quantify microbial contamination in non-sterile pharmaceutical products, in accordance with pharmacopeial guidelines (USP, IP, EP).
Click to read the full article.

Analytical Method Development V 2.0

Analytical Method Development: Total Viable Count Method Optimization – V 2.0

Posted on By

This SOP defines the optimized procedure for determining the Total Viable Count (TVC) of aerobic microorganisms (bacteria and fungi) present in pharmaceutical products using plate count techniques, supporting regulatory compliance and quality control objectives.
Click to read the full article.

Analytical Method Development V 2.0

Analytical Method Development: Development of Sterility Test Protocol – V 2.0

Posted on By

This SOP describes the procedure for developing a validated sterility test protocol to detect viable contaminating microorganisms in sterile pharmaceutical products using the membrane filtration and direct inoculation methods in accordance with pharmacopeial standards.
Click to read the full article.

Analytical Method Development V 2.0

Analytical Method Development: BET Method Development (Bacterial Endotoxins Test) – V 2.0

Posted on By

This SOP outlines the procedure for developing a validated method for the Bacterial Endotoxins Test (BET) using the gel-clot, turbidimetric, and chromogenic techniques to detect and quantify endotoxins in parenteral products and water for injection (WFI).
Click to read the full article.

Analytical Method Development V 2.0

Analytical Method Development: Suitability Testing for Microbial Methods – V 2.0

Posted on By

This SOP outlines the procedure for performing suitability testing (also known as method verification) of microbial limit tests to ensure that the product under evaluation does not inhibit microbial recovery, in accordance with USP and guidelines.
Click to read the full article.

Analytical Method Development V 2.0

Analytical Method Development: Pathogen Detection Method Development – V 2.0

Posted on By

This SOP outlines the procedure for the development and validation of test methods to detect specified pathogenic microorganisms in non-sterile pharmaceutical products as per regulatory requirements in USP , IP, and EP.
Click to read the full article.

Analytical Method Development V 2.0

Analytical Method Development: Development of Environmental Monitoring Plates – V 2.0

Posted on By

This SOP defines the procedure for preparation, validation, and usage of environmental monitoring plates (settle plates and contact plates) for microbial monitoring of cleanroom environments and controlled areas in pharmaceutical manufacturing and analytical areas.
Click to read the full article.

Analytical Method Development V 2.0

Analytical Method Development: Growth Promotion Test Protocol Development – V 2.0

Posted on By

This SOP outlines the procedure for developing a protocol for Growth Promotion Tests (GPT) of microbiological culture media to verify its ability to support the growth of suitable microorganisms, as per pharmacopeial guidelines.
Click to read the full article.

Analytical Method Development V 2.0

Analytical Method Development: Water Bioburden Estimation Method – V 2.0

Posted on By

This SOP defines the method for estimation of microbial bioburden in pharmaceutical water systems, including Purified Water (PW) and Water for Injection (WFI), using membrane filtration and standard plate count techniques in accordance with pharmacopeial guidelines.
Click to read the full article.

Analytical Method Development V 2.0

Posts pagination

Previous 1 … 12 13 14 … 38 Next

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Free GMP Video Content

Before You Leave...

Don’t leave empty-handed. Watch practical GMP scenarios, inspection lessons, deviations, CAPA thinking, and real compliance insights on our YouTube channel. One click now can save you hours later.

  • Practical GMP scenarios
  • Inspection and compliance lessons
  • Short, useful, no-fluff videos
Visit GMP Scenarios on YouTube
Useful content only. No nonsense.